UK variant of Coronavirus feared to undermine protection given by vaccines against developing COVID-19

▴ UK variant of Coronavirus feared to undermine protection given by vaccines against developing COVID-19
It was reported that the British variant, which is more infectious but not necessarily more deadly than others variant

The head of the UK’s genetic surveillance programme said, the Coronavirus variant first found in the British region of Kent is a concern because it could undermine the protection given by vaccines against developing COVID-19.

Sharon Peacock, director of the COVID-19 Genomics UK consortium, also said the variant was dominant in the UK and was likely to sweep the world, in all probability. She said vaccines were so far effective against the variants in the United Kingdom, but that mutations could potentially undermine the shots.

There are three major known variants that are worrying scientists: The South African variant, the so-called UK or Kent variant, and the Brazilian variant.

The British variant, which is more infectious but not necessarily more deadly than others, was likely to sweep the world, Peacock said. The two COVID-19 vaccines developed by Pfizer/BioNTech and AstraZeneca protect against the main British variant.

Meanwhile, the Covid-19 recovery rate in the India has improved 97.32 per cent. Health Ministry said, in the last 24 hours 15,8,58 people were discharged. With this 1,05,89,230 have recovered from Covid-19.

In the last 24 hours, 9,309 new COVID-19 cases and 87 deaths were reported. With this total cases reached 1 crore 8 lakh 80 thousand 603. The death toll has touched 1 lakh 55 thousand 447. The active cases are now at 1,35,926. More than 75 lakh people have been vaccinated in the country so far. 

Tags : #COVID-19Variant #UKVariant #LatestCOVIDNews12thFeb #SouthAfricanVariant #BrazilianVariant #RecoveryRate #COVIDDeaths

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Healthcare Startups to Watch Out for in 2025December 20, 2024
Biobank Blueprint: Redefining Diabetes Diagnosis and Treatment in IndiaDecember 20, 2024
The Future of Malaria Prevention: Can This Vaccine Eliminate the Disease?December 20, 2024
Why the World Trusts Indian Pharmaceuticals for Life-Saving SolutionsDecember 20, 2024
International Tsunami Conference Concludes at AmritapuriDecember 20, 2024
Prestige Marks 75 Years of Revolutionizing Home Cooking with Iconic Innovative ProductsDecember 20, 2024
Revolutionizing Education: Online Learning Platforms Transforming Study Materials for Board and Competitive ExamsDecember 19, 2024
Why Your Blood Pressure Reading Might Be a Lie and How to Fix ItDecember 19, 2024
Vaccines, Cards, and Digital Records: How India is Fighting Healthcare InequalityDecember 19, 2024
Bridging Borders: Sri Lanka’s President Explores India’s Healthcare and HeritageDecember 19, 2024
Jeevan Jyoti Project Brings Eye Care to Alwar's Rural CommunitiesDecember 19, 2024
Crompton Launches New Range of Decorative Wall Lights Providing a Perfect Blend of Uniqueness & AestheticsDecember 19, 2024
Can One Injection End Decades of HIV Inequality?December 19, 2024
Multi-Organ Marvel: How a 12-Hour Surgery Gave a Businessman New LifeDecember 19, 2024
Jupiter Hospital Celebrates BMT Heroes: Honoring Patients, Donors, and Advancing Care with New MilestonesDecember 18, 2024
Beware of Fraudulent Activities in the Name of Asian HospitalDecember 17, 2024
Why Feeling Lonely Can Be as Dangerous as Smoking for Your BrainDecember 17, 2024
Rethinking Intelligence: How Brain Connectivity Defines Our Intellectual PotentialDecember 17, 2024
Lonely in a Crowd: When Socializing Fails to Heal Young MindsDecember 17, 2024
How many hours of sleep are children getting on average now compared to before the pandemic?December 17, 2024